The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)Mohammed Al Ghobain, Majed Al Jeraisy, Al Saad et al.|Journal of Infection and Public Health|2022Cited by 6